Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Extended Management and Measurement of Autism (EMMA)

This study has been terminated.
Sponsor:
Collaborator:
Autism Speaks
Information provided by:
Neuropharm
ClinicalTrials.gov Identifier:
NCT00787111
First received: November 5, 2008
Last updated: February 22, 2010
Last verified: February 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2009
  Primary Completion Date: April 2009 (Final data collection date for primary outcome measure)